PT HDI

PT Harmoni Dinamik Indonesia (HDI) is a prominent health and wellness company specializing in bee-based nutritional supplements and therapeutic products. The company leverages the bioactive properties of honey, propolis, royal jelly, and bee pollen to develop a range of health solutions aimed at immune support and general well-being. HDI is particularly distinguished by its clinical research efforts, notably for its proprietary propolis extract, Propoelix, which has been studied as an adjunctive therapy for Dengue Fever and COVID-19 in Indonesian hospitals. Headquartered in Jakarta, the company operates through a robust social selling model across Southeast Asia. HDI remains a key player in the regional nutraceutical market, focusing on the intersection of traditional natural ingredients and modern clinical validation.